These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9822799)

  • 61. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of a role for the turkey posterior pituitary in prolactin release.
    el Halawani ME; Silsby JL; Koike TI; Robinzon B
    Gen Comp Endocrinol; 1992 Sep; 87(3):436-42. PubMed ID: 1426946
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
    Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
    Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autocrine control of prolactin secretion by vasoactive intestinal peptide.
    Nagy G; Mulchahey JJ; Neill JD
    Endocrinology; 1988 Jan; 122(1):364-6. PubMed ID: 3335213
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
    Sanyal S; Van Tol HH
    Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of vasoactive intestinal peptide receptor messenger RNA in the hypothalamus and pituitary throughout the turkey reproductive cycle.
    Chaiseha Y; Youngren OM; El Halawani ME
    Biol Reprod; 2004 Mar; 70(3):593-9. PubMed ID: 14568918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion.
    Porter TE; Grandy D; Bunzow J; Wiles CD; Civelli O; Frawley LS
    Endocrinology; 1994 Mar; 134(3):1263-8. PubMed ID: 8119166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
    López FJ; Dominguez JR; Sánchez-Franco F; Negro-Vilar A
    Endocrinology; 1989 Jan; 124(1):527-35. PubMed ID: 2909379
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serotonergic stimulation of prolactin secretion is inhibited by vasoactive intestinal peptide immunoneutralization in the turkey.
    el Halawani ME; Youngren OM; Rozenboim I; Pitts GR; Silsby JL; Phillips RE
    Gen Comp Endocrinol; 1995 Jul; 99(1):69-74. PubMed ID: 7657159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of dopamine in prolactin release induced by electrical stimulation of the hypothalamus of the female turkey (Meleagris gallopavo).
    el Halawani ME; Youngren OM; Silsby JL; Phillips RE
    Gen Comp Endocrinol; 1991 Dec; 84(3):360-4. PubMed ID: 1808016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pituitary prolactin messenger ribonucleic acid levels in incubating and laying hens: effects of manipulating plasma levels of vasoactive intestinal polypeptide.
    Talbot RT; Hanks MC; Sterling RJ; Sang HM; Sharp PJ
    Endocrinology; 1991 Jul; 129(1):496-502. PubMed ID: 2055202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long term exposure to dopamine reverses the inhibitory effect of endothelin-1 on prolactin secretion.
    Kanyicska B; Livingstone JD; Freeman ME
    Endocrinology; 1995 Mar; 136(3):990-4. PubMed ID: 7867609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
    Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
    Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
    Carrillo AJ; Phelps CJ
    Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of peptide histidine isoleucine on in vitro and in vivo prolactin secretion in the turkey.
    Proudman JA; Opel H
    Poult Sci; 1990 Jul; 69(7):1209-14. PubMed ID: 2235837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
    Murai I; Reichlin S; Ben-Jonathan N
    Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.